Sign In
Buy GWLIF
Great-West Lifeco Earnings Calls
| Release date | May 06, 2026 |
| EPS estimate | $0.94 |
| EPS actual | $0.99 |
| EPS Surprise | 4.90% |
| Revenue estimate | 1.065B |
| Revenue actual | 5.544B |
| Revenue Surprise | 420.35% |
| Release date | Feb 11, 2026 |
| EPS estimate | $0.94 |
| EPS actual | $0.99 |
| EPS Surprise | 5.10% |
| Revenue estimate | 1.109B |
| Revenue actual | 943.747M |
| Revenue Surprise | -14.87% |
| Release date | Nov 05, 2025 |
| EPS estimate | $0.87 |
| EPS actual | $1.30 |
| EPS Surprise | 48.74% |
| Revenue estimate | 1.022B |
| Revenue actual | 8.52B |
| Revenue Surprise | 733.34% |
| Release date | Aug 05, 2025 |
| EPS estimate | $0.86 |
| EPS actual | $0.729 |
| EPS Surprise | -15.43% |
| Revenue estimate | - |
| Revenue actual | 4.373B |
Last 4 Quarters for Great-West Lifeco
Below you can see how GWLIF performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Aug 05, 2025 |
| Price on release | $37.98 |
| EPS estimate | $0.86 |
| EPS actual | $0.729 |
| EPS surprise | -15.43% |
| Date | Price |
|---|---|
| Jul 30, 2025 | $37.62 |
| Jul 31, 2025 | $37.62 |
| Aug 01, 2025 | $37.53 |
| Aug 04, 2025 | $38.04 |
| Aug 05, 2025 | $37.98 |
| Aug 06, 2025 | $39.34 |
| Aug 07, 2025 | $38.98 |
| Aug 08, 2025 | $38.86 |
| Aug 11, 2025 | $38.46 |
| 4 days before | 0.95% |
| 4 days after | 1.26% |
| On release day | 3.58% |
| Change in period | 2.23% |
| Release date | Nov 05, 2025 |
| Price on release | $42.11 |
| EPS estimate | $0.87 |
| EPS actual | $1.30 |
| EPS surprise | 48.74% |
| Date | Price |
|---|---|
| Oct 30, 2025 | $42.39 |
| Oct 31, 2025 | $42.41 |
| Nov 03, 2025 | $42.45 |
| Nov 04, 2025 | $42.25 |
| Nov 05, 2025 | $42.11 |
| Nov 06, 2025 | $43.05 |
| Nov 07, 2025 | $42.61 |
| Nov 10, 2025 | $42.91 |
| Nov 11, 2025 | $43.47 |
| 4 days before | -0.661% |
| 4 days after | 3.23% |
| On release day | 2.24% |
| Change in period | 2.55% |
| Release date | Feb 11, 2026 |
| Price on release | $44.31 |
| EPS estimate | $0.94 |
| EPS actual | $0.99 |
| EPS surprise | 5.10% |
| Date | Price |
|---|---|
| Feb 05, 2026 | $45.84 |
| Feb 06, 2026 | $45.10 |
| Feb 09, 2026 | $44.13 |
| Feb 10, 2026 | $44.40 |
| Feb 11, 2026 | $44.31 |
| Feb 12, 2026 | $44.78 |
| Feb 13, 2026 | $45.16 |
| Feb 17, 2026 | $46.51 |
| Feb 18, 2026 | $46.12 |
| 4 days before | -3.34% |
| 4 days after | 4.08% |
| On release day | 1.06% |
| Change in period | 0.611% |
| Release date | May 06, 2026 |
| Price on release | $53.43 |
| EPS estimate | $0.94 |
| EPS actual | $0.99 |
| EPS surprise | 4.90% |
| Date | Price |
|---|---|
| Apr 30, 2026 | $53.46 |
| May 01, 2026 | $54.20 |
| May 04, 2026 | $53.94 |
| May 05, 2026 | $53.85 |
| May 06, 2026 | $53.43 |
| May 07, 2026 | $55.77 |
| May 08, 2026 | $54.65 |
| May 11, 2026 | $55.58 |
| May 12, 2026 | $55.36 |
| 4 days before | -0.0561% |
| 4 days after | 3.60% |
| On release day | 4.37% |
| Change in period | 3.54% |
Great-West Lifeco Earnings Call Transcript Summary of Q1 2026
Great-West reported a strong start to 2026 with double-digit base earnings growth across all operating segments. Key financial highlights: base earnings grew ~20% year-over-year, base EPS grew 23%, and base ROE exceeded the 19% medium-term objective (19.1%). Empower (U.S. Retirement & Wealth) delivered double-digit base earnings growth and Wealth grew ~65% year-over-year; Empower now manages ~$2 trillion in client assets and is focused on capturing rollovers and deeper customer relationships. Capital & Risk Solutions (CRS) showed very strong momentum driven by demand for capital solutions (now roughly 60% of CRS earnings) and favorable mortality experience. Great-West remains highly cash generative: Holdco cash was ~$2.1 billion at quarter-end, LICAT ratio was 129% (expected to be maintained >125%), free cash flow was ~85% of base earnings, and organic capital generation exceeded 80% of base earnings. The company repurchased about $567 million of common shares in Q1 and expects capital returns at least in line with 2025 unless compelling M&A emerges. Management reiterated confidence in sustaining 19%+ base ROE over the medium term, emphasized the shift to a more capital-light mix, disciplined risk controls (particularly in CRS), and continued investments in Empower (brand, digital/AI, product expansion).
